On November 8, 2023 Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics designed to modulate the tumor microenvironment to elicit a potent and durable anti-tumor response, reported that company leadership will present at two upcoming investor conferences in November (Press release, Bicara Therapeutics, NOV 8, 2023, View Source;utm_medium=rss&utm_campaign=bicara-therapeutics-to-present-at-upcoming-november-investor-conferences-2 [SID1234637249]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2023 Healthcare Conference on Wednesday, November 15 at 9:10 a.m. ET in New York, NY.
Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30 at 12:30 p.m. ET in New York, NY.